Clinicopathological and immunological characterization of RNA m6A methylation regulators in ovarian cancer
Abstract Background N6‐methyladenosine (m6A) modification is one of the critical gene regulatory mechanisms implicated in cancer biology. However, the roles of m6A regulators in ovarian cancer are still poorly understood. Methods We integrated multiple databases including Gene Expression Omnibus (GE...
Main Authors: | Qingying Wang, Qinyi Zhang, Qingxian Li, Jing Zhang, Jiawen Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.1547 |
Similar Items
-
Association Between Succinate Receptor SUCNR1 Expression and Immune Infiltrates in Ovarian Cancer
by: Jiawen Zhang, et al.
Published: (2020-08-01) -
m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer
by: Cheng Zhang, et al.
Published: (2021-01-01) -
Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer
by: Jing Gu, et al.
Published: (2021-07-01) -
Identification of a Gene Set Correlated With Immune Status in Ovarian Cancer by Transcriptome-Wide Data Mining
by: Lili Fan, et al.
Published: (2021-07-01) -
The prognostic values of m6A RNA methylation regulators in uveal melanoma
by: Jing Tang, et al.
Published: (2020-07-01)